Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-component reactions and evolutionary chemistry.

Lutz Weber1

  • 1Morphochem, Gmunderstr. 37, D-81379 München, Germany. lutz.weber@morphchem.de

Drug Discovery Today
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistics and Ontology of Published Small Molecule Ring Systems.

Molecular informatics·2026
Same author

Hyperparathyroidism Is an Independent Risk Factor for Allograft Dysfunction in Pediatric Kidney Transplantation.

Kidney international reports·2023
Same author

Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2022
Same author

Acute dialysis in children: results of a European survey.

Journal of nephrology·2019
Same author

Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells.

Beilstein journal of organic chemistry·2019
Same author

HNF1B nephropathy has a slow-progressive phenotype in childhood-with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry.

Pediatric nephrology (Berlin, Germany)·2019

Multi-component reactions (MCRs) offer an efficient synthetic route to diverse compounds. Combining MCRs with predictive modeling accelerates drug discovery and optimization, marking a significant advancement in medicinal chemistry.

Area of Science:

  • Medicinal Chemistry
  • Synthetic Organic Chemistry
  • Computational Chemistry

Background:

  • Multi-component reactions (MCRs) are increasingly recognized for their efficiency in synthesizing diverse chemical entities.
  • The application of MCRs is expanding beyond academic curiosity into practical drug discovery pipelines.
  • Traditional drug discovery methods face challenges in generating diverse compound libraries efficiently.

Purpose of the Study:

  • To highlight the evolving role of Multi-component reactions (MCRs) in modern drug discovery.
  • To introduce a novel approach combining MCRs with predictive modeling for drug development.
  • To demonstrate the power of integrated computational and synthetic strategies in identifying drug leads.

Main Methods:

  • Utilizing Multi-component reactions (MCRs) for the rapid generation of compound libraries.

Related Experiment Videos

  • Employing evolutionary in silico prediction algorithms to assess drug-like properties.
  • Integrating in vitro assays for biological property validation.

    • Main Results:

    • Demonstrated the efficiency of MCRs in producing a wide array of novel chemical structures.
    • Successfully combined MCRs with predictive modeling to identify promising drug candidates.
    • Validated the predicted biological potential of selected compounds through in vitro experiments.

    Conclusions:

    • Multi-component reactions (MCRs) represent a powerful and efficient strategy for drug discovery.
    • The integration of MCRs with in silico and in vitro predictive tools significantly enhances lead discovery and optimization.
    • This combined approach offers a novel and potent methodology for accelerating the development of new therapeutics.